Development of Clinician-Reported Outcome and Patient-Reported Outcome Measures for Eyebrow, Eyelash, and Nail Assessment in Alopecia Areata

August 2020 in “ American Journal of Clinical Dermatology ”

Kathleen W. Wyrwich, Helen Kitchen, S.L. Knight, Natalie V. J. Aldhouse, Jake Macey, Fabio P. Nunes, Yves Dutronc, Natasha Atanaskova Mesinkovska, Justin Ko, Brett King

Alopecia Areata eyebrow assessment eyelash assessment nail assessment Clinician-Reported Outcome Patient-Reported Outcome AA ClinRO PRO

Studysummary This study concluded that the ClinRO and PRO measures, along with their photoguides, offer clear and meaningful assessments for patients with alopecia areata concerning eyebrow, eyelash, and nail appearance, as well as eye irritation. Our plain-language summary of this paper — not a Tressless recommendation.

The development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) measures for assessing eyebrow, eyelash, and nail appearance in patients with Alopecia Areata (AA) provided valuable tools for evaluating outcomes that were significant to patients. These measures, along with photoguides and a PRO measure for eye irritation, offered clear and meaningful assessments, enhancing the understanding of patient experiences and treatment impacts in AA.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials

86 citations , January 2020 in “British Journal of Dermatology”

This study developed the Alopecia Areata Investigator Global Assessment (AA-IGA) to measure scalp-hair loss in alopecia areata patients, incorporating perspectives of both patients and clinicians to define treatment success.

research Nail Changes in Alopecia Areata: An Update and Review

45 citations , January 2018 in “International Journal of Dermatology”

This review explores nail changes associated with alopecia areata, noting their prevalence and impact on appearance and function, but reports no new clinical findings; the authors call for larger controlled trials.

research Development of Uniform Protocol for Alopecia Areata Clinical Trials

2 citations , November 2015 in “Journal of Investigative Dermatology Symposium Proceedings”

This article discusses the creation of Alopecia Areata Uniform Protocols by the National Alopecia Areata Foundation to standardize clinical trials for alopecia areata treatments and reports no new results.

research Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss

17 citations , December 2013 in “Journal of Investigative Dermatology Symposium Proceedings”

In this study, once-daily treatment with bimatoprost 0.03% solution significantly increased eyelash growth, thickness, and darkness in patients with chemotherapy-induced eyelash loss compared to placebo, and was well tolerated over one year.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations , May 2011 in “Dermatologic Therapy”

This article reviews the characteristics, associations, and diagnostic criteria for alopecia areata and reports no new clinical findings; the authors note the disease's unpredictable course and variable prognosis.